Glycomine's Mission for Rare Diseases
Glycomine is committed to developing therapeutics for serious rare diseases, the vast majority of which do not have any disease-modifying treatment options available. There are approximately 7,000 rare disorders worldwide. Each day more are being discovered. Even though the number of patients affected by any single disease may total several hundred or thousand, it is estimated the total number of people affected by all such diseases is more than 20 million in the U.S. alone.